These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 15362740)

  • 1. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
    da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
    Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
    Kim YW; Park YK; Yoon TY; Lee SM
    Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients.
    Saetta A; Lazaris AC; Michalopoulos NV; Davaris PS
    Hepatogastroenterology; 2001; 48(41):1284-8. PubMed ID: 11677947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
    Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions.
    Ajiki T; Onoyama H; Yamamoto M; Asaka K; Fujimori T; Maeda S; Saitoh Y
    Hepatogastroenterology; 1996; 43(9):521-6. PubMed ID: 8799388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
    Billo P; Marchegiani C; Capella C; Sessa F
    Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas.
    Saetta A; Koilakou SV; Michalopoulos NV; Davaris PS
    Hepatogastroenterology; 2003; 50(54):1799-802. PubMed ID: 14696408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
    Wu W; Pan C; Yu H; Gong H; Wang Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder.
    Fujii K; Yokozaki H; Yasui W; Kuniyasu H; Hirata M; Kajiyama G; Tahara E
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):461-6. PubMed ID: 8781743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of xanthogranulomatous cholecystitis: precancerous lesion of gallbladder cancer?
    Takada M; Horita Y; Okuda S; Okumoto S; Samizo M; Wada T; Kuroda Y; Maeda S
    Hepatogastroenterology; 2002; 49(46):935-7. PubMed ID: 12143246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of aggressive treatment of stage IV gallbladder cancer and predictors of survival.
    Todoroki T; Takahashi H; Koike N; Kawamoto T; Kondo T; Yoshida S; Kashiwagi H; Otsuka M; Fukao K; Saida Y
    Hepatogastroenterology; 1999; 46(28):2114-21. PubMed ID: 10521952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallbladder cancer in a high risk area: morphological features and spread patterns.
    Roa I; Araya JC; Villaseca M; Roa J; de Aretxabala X; Ibacache G
    Hepatogastroenterology; 1999; 46(27):1540-6. PubMed ID: 10430291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [p53 and p27 gene expression in subserosal gallbladder carcinoma].
    Roa E I; Lantadilla H S; Ibacache S G; de Aretxabala U X
    Rev Med Chil; 2009 Aug; 137(8):1017-22. PubMed ID: 19915764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of N-myristoyltransferase in gallbladder carcinomas.
    Rajala RV; Radhi JM; Kakkar R; Datla RS; Sharma RK
    Cancer; 2000 May; 88(9):1992-9. PubMed ID: 10813869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosquamous/squamous cell carcinoma of the gallbladder.
    Chan KM; Yu MC; Lee WC; Jan YY; Chen MF
    J Surg Oncol; 2007 Feb; 95(2):129-34. PubMed ID: 17262729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.
    Roa JC; Roa I; Correa P; Vo Q; Araya JC; Villaseca M; Guzmán P; Schneider BG
    J Gastroenterol; 2005 Jan; 40(1):79-86. PubMed ID: 15692793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyalinizing cholecystitis and associated carcinomas: clinicopathologic analysis of a distinctive variant of cholecystitis with porcelain-like features and accompanying diagnostically challenging carcinomas.
    Patel S; Roa JC; Tapia O; Dursun N; Bagci P; Basturk O; Cakir A; Losada H; Sarmiento J; Adsay V
    Am J Surg Pathol; 2011 Aug; 35(8):1104-13. PubMed ID: 21716080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.
    Kim HS; Kim GY; Lim SJ; Park YK; Kim YW
    Hum Pathol; 2010 Nov; 41(11):1609-16. PubMed ID: 20688353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gallbladder carcinoma. Our experience].
    Gentilli S; Fronticelli CM; Ferrero A; Quiriconi F; Corradino R
    Minerva Chir; 1996 Apr; 51(4):183-6. PubMed ID: 8927266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis.
    Yanagisawa N; Yamashita K; Kuba T; Okayasu I
    Anticancer Res; 2010 Nov; 30(11):4443-9. PubMed ID: 21115891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.